Clinical Trial Update: A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports an active-not-recruiting Phase 1 study evaluating comparative formulations of Niraparib and Abiraterone Acetate in men with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Niraparib (Niraparib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING